Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative chemotherapy for locally advanced colorectal cancer (phase II)
jRCTs051180167Phase 2Completed
- Start
- Jan 2017
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cetuximab, oxaliplatin, fluorouracil, folinic acid, tegafur and 1 more in colorectal cancer (CRC), rectal cancer and colon cancer (2 arms). Primary endpoints: Radiologic response rate at 12 weeks and Induction rate of curative operation. Started Jan 2017; status: completed.
02
Drugs
cetuximaboxaliplatinfluorouracilfolinic acidtegafur
03
Conditions
colorectal cancer (CRC)rectal cancercolon cancer
Beyond the preview
Go deeper on jRCTs051180167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051180167.